Holen Sie sich die Stockscreener-App
123.82
3.36%
-4.24
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
BWS Financial initiates Twist Bioscience stock with sell rating - Investing.com
TWST Initiates Coverage On UBS -- Rating Set at Neutral with $144 Target - GuruFocus
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference - BioSpace
After $14M August sale, Twist Bioscience (NASDAQ: TWST) investor plans another stock sale - Stock Titan
Officer at Twist Bioscience (TWST) preps 907-share sale - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell shares, including stock to cover taxes - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer plans about $50K stock sale - Stock Titan
Cathie Wood’s ARK reveals stake in Twist Bioscience (NASDAQ: TWST) - Stock Titan
Claim your share of the $17 million Twist Bioscience securities class action settlement - Claim Depot
An investor holds voting power over 8.8M Twist Bioscience (TWST) shares - Stock Titan
Twist Bioscience (TWST) Rallied as AI and Pharma Drive DNA Demand - Yahoo Finance
About Twist Bioscience Corporation • Robinhood Token - Coinbase
Cathie Wood’s ARK sees major stock moves with Robinhood and Twist Bioscience - Investing.com
Twist Bioscience Corp (TWST) Shares Fall 3.0% -- What GF Score o - GuruFocus
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - Moomoo
Twist Bioscience Corp (TWST) Stock Down 5.0% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience Slides as Investors Appear to Cool on Recent AI-Fueled Rally - Quiver Quantitative
Twist Bioscience Corp (TWST) Key Financial Ratios – Valuation, Profitability & More - Value Research
Twist Bioscience (NASDAQ: TWST) insider sells millions in stock - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer sets 854-share sale tied to equity taxes - Stock Titan
Guggenheim reiterates Twist Bioscience stock rating on AI drug discovery potential - Investing.com
Twist Bioscience Executive Dennis Cho Sells 14,205 Shares Under 10b5-1 Plan in August 2026 - Kalkine Media
Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook - StocksToTrade
Twist Bioscience (NASDAQ: TWST) seller plans more after $14.2M August stock trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer adds $189K sale after $2.1M June trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) holder to sell 1,965 shares for taxes, compensation - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer booked $1.84M in one sale, now plans more stock trades - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell 669 shares - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer to sell 4,046 shares after $9.2M August sale - Stock Titan
Twist Bioscience Corp (TWST) Stock Down 4.3% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience (TWST) COO sells 78K shares under 10b5-1 plan - Stock Titan
Twist Bioscience stock hits 52-week high at 143.1 USD - Investing.com
Twist Bioscience (NASDAQ:TWST) Shares Gap DownHere's What Happened - MarketBeat
Twist Bioscience stock hits 52-week high at 143.1 USD By Investing.com - Investing.com Canada
Twist Bioscience benefits from Claude's advances in protein design - marketscreener.com
Twist Bioscience Registers 35,114 Shares for Resale by Invenra - Minichart
Twist Bioscience files prospectus supplement for Invenra share resale - Investing.com
Twist Bioscience (NASDAQ: TWST) clears path for 35K-share resale - Stock Titan
Twist Bioscience Stock Rallies As Guidance And Targets Jump - StocksToTrade
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report - Benzinga
Short seller Scorpion Capital bets against Twist Biosciences questioning AI partnership claims - Investing.com
Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project - marketscreener.com
Twist Bioscience (NASDAQ: TWST) officer may sell $1.84M in shares - Stock Titan
Twist Bioscience jumps as investors build on strong guidance and AI-drug-discovery enthusiasm - Quiver Quantitative
TWST Looks 163.5% Overvalued on GF Value™ - GuruFocus
Twist Bioscience Up Over 17%, on Track for Highest Close Since April 2021 -- Data Talk - Bitget
Why is Twist Bioscience stock surging today? By Investing.com - Investing.com Nigeria
Twist Bioscience (NASDAQ:TWST) Hits New 52-Week HighShould You Buy? - MarketBeat
Why is Twist Bioscience stock surging today? - Investing.com
Twist Bioscience Selected as Independent Evaluator in Anthropic's AI-Driven Protein Design Initiative - Kalkine Media
Form 8K Twist Bioscience Corp For: 19 August By Investing.com - Investing.com Nigeria
Twist Bioscience selected as evaluator for Anthropic AI protein design project - Investing.com
Anthropic selects Twist Bioscience as independent evaluator for AI-designed protein testing - TradingView
Twist Bio stock up on Anthropic announcement (TWST:NASDAQ) - Seeking Alpha
Twist Bioscience (NASDAQ: TWST) insider plans multimillion-dollar stock sale - Stock Titan
A Look at Twist Bioscience Corp (TWST) After 5.0% Gain -- GF Val - GuruFocus
Twist Bioscience (TWST) Is Down 5.1% After Upsized Equity Raise And Guidance Hike Has The Bull Case Changed? - simplywall.st
Bank of America Corp DE Grows Stake in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience CEO Emily Leproust Executes Sale of 19,952 Shares via 10b5-1 Plan - Kalkine Media
Twist Bioscience Corp (TWST) Stock Down 5.4% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience Director Katryn Blake Executes Sell-to-Cover of 2,240 Shares for RSU Tax Obligations - Kalkine Media
Twist Bioscience (TWST) director sells 2,240 shares to cover RSU tax - Stock Titan
Twist Bioscience (TWST): ARK Investment Management reports 4.55M-share, 7.31% stake - Stock Titan
Twist Bioscience (NASDAQ:TWST) Trading Down 4.3%Here's What Happened - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
1.84%
1.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):